SCHEMBL12416707

SCHEMBL12416707

CC1(CNS(=O)(=O)c2ccc(-c3ccccc3)cc2)NC(=O)NC1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 2/20 0.57
MMP1 P03956 2/20 0.47
MMP12 P39900 2/20 0.47
GAA P10253 1/20 0.47
MMP2 P08253 3/20 0.44
MMP9 P14780 3/20 0.44
MMP3 P08254 2/20 0.44
MMP7 P09237 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
MMP14 P50281 1/20 0.44
MEP1B Q16820 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
MGAT2 Q10469 2/20 0.42
ALDH1A1 P00352 2/20 0.41
KAT6A Q92794 1/20 0.40
LIPG Q9Y5X9 2/20 0.39
LIPC P11150 1/20 0.39
ADAMTS4 O75173 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12378665 0.86 ADAM17 (0.56) ADAM17MMP12MMP2MMP9MMP3
SCHEMBL12378820 0.84 ADAM17 (0.51) ADAM17MMP1GAAMMP2MMP9
SCHEMBL941785 0.80 ALDH1A1 (0.44) ADAM17MMP1MMP2MMP9MMP3
SCHEMBL12416690 0.74 ADAM17 (0.57) ADAM17MMP12MMP2MMP9MMP3
SCHEMBL6841100 0.71 ALDH1A1 (0.46) MMP2MMP9MMP3MMP8HDAC1
SCHEMBL14085484 0.70 ALDH1A1 (0.46) ADAM17MMP2MMP9MMP3MMP8
SCHEMBL7066933 0.70 MMP1 (0.64) ADAM17MMP1MMP12GAAMMP2
SCHEMBL12416702 0.70 ALDH1A1 (0.48) ADAM17MMP12MMP2MMP9MMP3
SCHEMBL31605375 0.69 TDP1 (0.44) ADAM17MMP1MMP12GAAMMP2
SCHEMBL12418505 0.69 ALDH1A1 (0.50) MMP2MMP9MMP8HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998961-B2 For treating conditions associated with UDP-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) SCHERING CORPORATION (US) 2011-08-16 US disclosed
US-20080226618-A1 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS SCHERING CORPORATION 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080226618-A1 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS LPXN, HAX1, LCT ADAM17 1995/4885MMP1 1224/4885MMP12 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.